We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK's Paxil CR, Avandamet Seized After cGMP Violations
GSK's Paxil CR, Avandamet Seized After cGMP Violations
March 11, 2005
GlaxoSmithKline (GSK) has halted distribution of its antidepressant Paxil CR and diabetes drug Avandamet because of ongoing concerns about the manufacturing quality of the products.